Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 10 2021
Historique:
received: 19 03 2021
accepted: 01 10 2021
entrez: 12 10 2021
pubmed: 13 10 2021
medline: 27 1 2022
Statut: epublish

Résumé

Systemic sclerosis (SSc) is characterized by fibrosis of the skin and various internal organs. However, there is limited knowledge concerning small-bowel lesions. We evaluated the clinical state of patients with SSc according to the capsule endoscopy (CE) findings. Sixty-five consecutive patients with SSc (61 females; mean age, 64.3 years) underwent CE at Hiroshima University Hospital between April 2012 and December 2019. SSc was subclassified into diffuse and limited cutaneous SSc. Among the 65 patients, 55 (51 females; mean age, 64.5 years; diffuse cutaneous SSc, 27 patients) were evaluated for the presence of fibrosis in the gastrointestinal tract by biopsy. Small-bowel lesions were detected in 27 (42%) patients with SSc. Type 1b angioectasia (Yano-Yamamoto classification) was more frequent in limited cutaneous SSc patients (p = 0.0071). The average capsule transit time of the esophagus was significantly longer in diffuse cutaneous SSc patients (p = 0.0418). There were more cases of Type 1a angioectasia in SSc patients without fibrosis. The average capsule transit time of the esophagus was significantly longer in SSc patients with fibrosis. Thus, this study revealed that the frequency of small-bowel angioectasia and gastrointestinal motility in patients with SSc differed depending on SSc subclassification and the presence of fibrosis.

Identifiants

pubmed: 34635790
doi: 10.1038/s41598-021-99775-y
pii: 10.1038/s41598-021-99775-y
pmc: PMC8505447
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20163

Informations de copyright

© 2021. The Author(s).

Références

Gastrointest Endosc. 2008 Jan;67(1):169-72
pubmed: 18155439
Hepatogastroenterology. 2012 Jun;59(116):955-9
pubmed: 22580642
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
Scand J Gastroenterol. 2016 Mar;51(3):281-7
pubmed: 26466551
Intern Med. 2017;56(12):1453-1457
pubmed: 28626168
Curr Gastroenterol Rep. 2019 Jan 15;21(1):3
pubmed: 30645678
PLoS One. 2016 Oct 5;11(10):e0163894
pubmed: 27706206
Semin Arthritis Rheum. 2010 Feb;39(4):269-77
pubmed: 18706680
Rheumatology (Oxford). 2016 Feb;55(2):315-9
pubmed: 26359329
Arthritis Rheum. 2000 Nov;43(11):2437-44
pubmed: 11083266
Scand J Rheumatol. 2016 Nov;45(6):499-506
pubmed: 27232525
Aliment Pharmacol Ther. 2014 Jul;40(2):189-99
pubmed: 24889779
Gastroenterology. 1977 Apr;72(4 Pt 1):650-60
pubmed: 300063
Digestion. 2014;89(3):225-31
pubmed: 24861046
Arthritis Rheum. 2003 Aug;48(8):2246-55
pubmed: 12905479
Therap Adv Gastroenterol. 2018 Jul 16;11:1756284818787408
pubmed: 30034534
Dig Dis Sci. 2017 Dec;62(12):3525-3535
pubmed: 28871499
Gastrointest Endosc. 2016 Jul;84(1):163-7
pubmed: 26907744
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):291-308
pubmed: 29622808
Rheum Dis Clin North Am. 2018 Feb;44(1):15-28
pubmed: 29149923
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):74-78
pubmed: 27310209
Endosc Int Open. 2020 Mar;8(3):E396-E400
pubmed: 32118112
Neurogastroenterol Motil. 2017 Jul;29(7):
pubmed: 28086261
Br J Rheumatol. 1989 Aug;28(4):281-6
pubmed: 2787182
Ann Intern Med. 1963 Dec;59:822-6
pubmed: 14082734
Gastrointest Endosc. 1980 Nov;26(4):134-8
pubmed: 6969679
Gastroenterol Res Pract. 2019 Dec 1;2019:5496242
pubmed: 31885542
Arthritis Rheum. 1980 May;23(5):581-90
pubmed: 7378088
J Gastroenterol Hepatol. 2014 Mar;29(3):511-6
pubmed: 23981241
Br J Surg. 1968 Sep;55(9):667-72
pubmed: 5676700
J Med Assoc Thai. 2002 Nov;85(11):1204-9
pubmed: 12546318
AJR Am J Roentgenol. 1977 Nov;129(5):789-94
pubmed: 410241
BMC Gastroenterol. 2015 Aug 25;15:108
pubmed: 26302944
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Rheumatology (Oxford). 2010 Sep;49(9):1770-5
pubmed: 20530510
Digestion. 2021;102(2):188-196
pubmed: 31574519
Gastroenterol Res Pract. 2016;2016:9671327
pubmed: 27980536

Auteurs

Sumio Iio (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Shiro Oka (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. oka4683@hiroshima-u.ac.jp.

Shinji Tanaka (S)

Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.

Akihiko Sumioka (A)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Akiyoshi Tsuboi (A)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Takaki Nojima (T)

Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.

Shintaro Hirata (S)

Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.

Yoshimi Matsuo (Y)

Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.

Eiji Sugiyama (E)

Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.

Michihiro Hide (M)

Department of Dermatology, Hiroshima University Hospital, Hiroshima, Japan.

Koji Arihiro (K)

Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.

Kazuaki Chayama (K)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH